These are aimed at giving patients more flexibility, reducing the cost burden and making adoption of these anti-obesity therapies easier
Among GLP-1 medications specifically, semaglutide has one of the longest half-lives: Exenatide (Byetta): approximately 2.4 hours, requires twice-daily injections Liraglutide (Saxenda, Victoza): approximately 13 hours, requires once-daily injections Dulaglutide (Trulicity): approximately 5 days, requires once-weekly injections Semaglutide (Ozempic, Wegovy): approximately 7 days, requires once-weekly injections Tirzepatide (Mounjaro, Zepbound): approximately 5 days, requires once-weekly injections Semaglutides seven-day half-life ties it with dulaglutide for the longest among currently approved GLP-1 medications
At Text2MD, that physician-guided model is central to how medical weight loss should work
Some people lose appetite to the point where they struggle to eat enough
Users are even expressing different preferences around where and how they shop